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1. Introduction 
Already 150 years ago, the German pathologist Rudolf Virchow postulated in his theory of 
the cellular pathology that cancer initiates from immature cells. But it still took 100 years 
until Sajiro Makino introduced the term "tumor stem cells" for a small subpopulation of cells 
that were insensitive to chemotherapy and had chromosomal features different from the 
bulk of cells (Makino, 1959). Although the existence of cancer stem cells (CSCs) was 
proposed over decades ago, only in the past decade increasing evidence supports that 
cancers contain a small subset of their own stem-like cells (Dalerba et al., 2007; Pardal et al., 
2003; Wicha et al., 2006). At present, these cells have been identified in human leukemias 
(Konopleva & Jordan, 2011), and more recently in solid tumors that include liver (Ma et al., 
2007), breast (Dontu et al., 2003), prostate (Lukacs et al., 2010), brain (Huang et al., 2010), 
colon (Kemper et al., 2010) and lung cancers (Sullivan & Minna, 2010). These studies suggest 
that, like normal stem cells, CSCs should be rare, quiescent, and capable of self-renewing 
and maintaining tumor growth and heterogeneity. Therefore, development of effective 
therapies that will specifically target CSCs may become a promising therapeutic option to 
fight cancer.  
The researches of CSCs are based on successful viable CSCs sorting. Universally accepted 
markers of CSCs are very important to cell sorting. In the last decade several molecular 
properties have been utilized to identify and characterize CSCs from different hematopoietic 
and solid tumors. The first markers used were cell surface proteins already known to define 
stem and progenitor cells, e.g. CD133 and CD166. Meanwhile, some surface markers that are 
associated with human and mouse stem cells are also found on cancer stem cells, such as 
CD34, CD117, Sca-1, and other markers, such as CD44, CD24, CD20 CD105, and CD326 
(EpCAM) have been found on cancer stem cells (Keysar & Jimeno, 2010). Furthermore, 
molecules that facilitate drug resistance in cancer cells like ABCB1 and ABCG2 were added 
to the list of putative CSC markers (Calcagno et al., 2010) as well as proteins for which no 
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involvement in stemness or cancerogenesis was known, e.g. CD20. Although CSCs have 
been isolated by cell surface markers such as CD24, CD44, and CD133 as well as on the basis 
of sphere formation after in vitro cultivation (Jordan et al., 2006), the identification of a 
putative cancer stem cell subpopulation with validated methods and markers for each 
tumor entity remains controversial. Because of this, suitable cells are needed for the analysis 
of CSCs biology.  
While the cells are stained with Hoe33342 (Hoe) vital dye, a cell-permeable DNA-specific 
bisbenzimidazole dye, the display of Hoe fluorescence simultaneously at two emission 
wavelengths localizes a distinct, small, non-stained cell population that is designated as side 
population (SP) cells. Because SP cells are known to have highly efficient pumps for the 
dyes, they are considered to be resistant to multi-chemotherapeutic drugs and to confer 
malignant phenotypes to tumors (Wu & Alman, 2008). More importantly, the SP cells 
express high levels of stem cell markers and low levels of differentiating markers 
(Haraguchi et al., 2006). Hence, the characterization of SP cells might be a useful tool for 
analysis of CSCs, especially when specific CSC surface markers are unknown.  
As an alternative approach, the SP phenomenon has been used to identify and isolate stem 
cell populations from a variety of tissues including bone marrow (Goodell, 2002), mammary 
gland (Welm et al., 2003), skin (Montanaro et al., 2003), liver (Wulf et al., 2003), lung (Majka 
et al., 2005), skeletal muscle (Meeson et al., 2004), limb (Umemoto et al., 2006), heart (Martin 
et al., 2004), and brain (Kim & Morshead, 2003). This approach overcomes the barrier of 
phenotypical markers and replaces it by more direct functional markers. The most widely 
accepted assays to obtain SP cells are efflux analysis of Hoe as well as further detection of 
known stem cell markers in cancer cells and verification by xenotransplantations. Such 
specific dye can only be excluded out of cells by the ATP-Binding Cassette (ABC) 
transporters, which is a stem-like characteristic. That is to say, only the cells with ABC 
transporters expression can exclude such dye. Thus, dye exclusion is a valuable technique to 
indirectly identify stem-like cells.  
The dye Hoe exclusion has been successfully applied in many tumors and corresponding cell 
lines. The blue fluorescent Hoe is a cell permeable bisbenzimidazole derivative that binds to 
the minor groove of DNA. After excitation of Hoe its emission can be measured 
simultaneously in the blue and red spectrum. But although Hoe enters viable cells, it is also 
actively pumped out by ABC transporters of the cell membrane (Scharenberg et al., 2002). 
There is mounting speculation that ABC transporters repress the maturation and 
differentiation of stem cells (Spangrude & Johnson, 1990). Although several subfamilies of 
genes coding for these transporters have been identified (ABCA, ABCB, ABCC, ABCD, 
ABCE, ABCF, ABCG), the best-known are: members of the ABCB and ABCG subfamilies, 
such as ABCB1 (MDR1, P-gp) and ABCG2 (Bcrp1) in humans (Choi, 2005). It has been 
demonstrated that the exclusion of Hoe by SP cells is an active process mainly involving 
Bcrp1 (Uchida et al., 2002). To determine the size of the SP, Verapamil, an L-type calcium 
channel blocking agent serves as an important control. Blocking the calcium channels 
inhibits the efflux of Hoe-dye from these cells, so it is then possible to gate for the side 
population, which is suspected to consist of cancer stem cells. However, the toxicity of Hoe 
should be addressed and always kept in mind when applying this dye to isolate putative 
CSCs. As Hoe binds to DNA, it can disrupt DNA replication during cell division. 
Consequently, it is potentially mutagenic and carcinogenic. This toxicity suggests a 
potentially severe limitation for the use of Hoe dye in combination with fluorescence 
activated cell sorting (FACS).  
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Rhodamine123 (Rho) is always used as a substrate of ABCB1/P-gp transporter to evaluate 
the toxicity of drugs (Vautier et al., 2008) and to examine the functional activity of P-gp in 
cultured cells (He & Ji, 2008). Like Hoe, it is actively pumped out of the cells by ABC 
transporters, e.g. ABCB1/P-gp protein (Zhou et al., 2001). Our study found that Rho was 
shown to be non-toxic to cells even at high concentrations, it can be an alternative to the use 
of Hoe.  
Hepatocellular carcinoma (HCC) is the fifth most common cancer and third most frequent 
cause of cancer deaths worldwide. It has been ranked the second leading cause of cancer 
death in China since the 1990s. The prognosis of HCC patients remains extremely poor, with 
a 5-year survival rate of less than 5%. HCC respond poorly to standard chemotherapy 
treatment regimens. The reasons for this clinical phenotype are believed to be based on 
cellular heterogeneity of the tumor and the presence of multidrug resistance genes, which 
encode for pumps that actively expel the cytotoxic substances. Because the Hoe and Rho 
efflux capacity of SP cells is also dependent on the presence of membrane pumps, we 
hypothesized that identification of the SP cells in HCC could potentially represent a suitable 
isolation method to evaluate stem cell-like tumor characteristics in HCC. It is widely 
accepted that the MHCC97 cell line has heterogeneity, but there are few methods to separate 
SP cells from this cell line. Thus, we investigate the method to isolate liver cancer stem like 
cells by Hoe or Rho efflux from MHCC97 cell line and detect the stem cell properties of the 
obtained SP cells.  
In this chapter, we will present the method that isolation of liver cancer stem like cells by 
Hoe or Rho efflux and discuss the advantages and disadvantages of the two methods.  
2. Methods and analysis 
We firstly examined in vitro cytotoxicity of Hoe and Rho, and then used both Hoe/FACS 
and Rho/FACS to enrich CSCs from the MHCC97 cell line (Key Laboratory for 
Carcinogenesis and Cancer Invasion, Liver Cancer Institute, Zhongshan Hospital, Fudan 
University, Shanghai, China). We tried different conditions detailed in methods to 
determine the optimal dye concentration. After cells were successfully sorted by the two 
methods, we obtained four typed cells: SP cells (low staining with Hoe) and NSP cells 
(high staining with Hoe), Rholow subpopulation cells (low Rho fluorescence and 
Verapamil negative) and Rhohigh subpopulation cells (high Rho fluorescence). Among 
them, SP and Rholow cells were CSC like cells. We compared the effects of Hoe and Rho on 
CSCs sorting and found the ability of Rho staining to separate subpopulations from the 
MHCC97 cell line is similar to Hoe staining. Based on the analysis of several CSCs’ 
characteristics, we found the Rholow cells had similar characters as the SP cells, such as high 
proliferative ability, high expression of stem cell markers (early hepatic marker AFP and 
CSCs marker CD133) and strong tumorigenicity in vivo. Specific methods of operation are 
as follows. 
2.1 Agents test 
Each compound was screened for possible cytotoxic effect with the Cytotoxicity Detection 
Kit (Roche Applied Science, Mannheim, Germany). This is a colorimetric assay for the 
quantification of lactate dehydrogenase activity released from the cytosol of damaged cells 
into the supernatant. Cytotoxicity was calculated as a percentage of the effect obtained  
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with the positive control (total cell lysis) (Storch et al., 2007). To guarantee the specificity  
of subpopulations, Verapamil (Sigma Chemical Co., St. Louis, MO) was used for second 
check. The influence of Verapamil on the fluorescence of the ABC transporter substrates  
was evaluated by adding increasing concentrations to Rho or Hoe solution. Among the 
tested compounds, only 8 μg/ml Hoe caused cytotoxic effect >50%. The cytotoxic effect 
caused by 6 μg/ml Hoe was 30.8%. Besides, when the concentration of Hoe was<4 μg/ml, it 
caused cytotoxic effect <30%. Through statistical analysis, the IC50 of Hoe was 7.52 μg/ml. 
For all Rho patterns (the concentrations ranged from 0.05 to 1 μg/ml), no cytotoxic effect 
was found. There was no quenching effect caused by Verapamil to both Hoe and Rho 
solutions. 
2.2 Cells culture and grouping 
The cells from the MHCC97 cell line were maintained in DMEM culture (Invitrogen, 
Karlsruhe, Germany), which was supplemented with 10% FCS, 2 mM glutamine, 1 mM 
HEPES, 100 U/ml penicillin G and 100 g/ml streptomycin (Invitrogen, Karlsruhe, 
Germany). These cells (at logarithmic growth phase) were randomly divided into four 
groups: group A (Hoe trial group), group B (Hoe control group), group C (Rho trial group) 
and group D (Rho control group). All the cells were cultured at 37 °C in a humidified 
atmosphere containing 5% CO2. 
2.2 Hoe/FACS 
2.2.1 Cells sorting by Hoe/FACS  
As a standard control, the cultured cells were sorted by Hoe/FACS. The single-cell 
suspension was prepared by passing through a 50 µm mesh filter and diluted to a working 
concentration of 1×106 cells/ml with ice-cold PBS containing 2% FCS. In group A the cells 
were stained with the Hoe dye (Sigma Chemical Co., St. Louis, MO) at a concentration of 6 
μg/ml (37 °C for 90 min) under mild shaking. In group B the cells were incubated in the 
presence of Verapamil (50 µM) and Hoe for 90 min at 37 °C. The Varapamil, which blocks 
the transporters responsible for Hoe exclusion, is applied to check the purity of the SP cells. 
After washed twice by PBS/2%FBS, the cells were incubated with 10 μg/ml 
propidiumiodide (PI) (Sigma Chemical Co., St. Louis, MO) for exclusion of dead cells. After 
excitation of the Hoe dye at 350 nmby ultra-violet (UV) laser on MoFlow (Cytomation Inc., 
Fort Collins CO., USA) and measurement of the fluorescence profile in two wave-lengths 
analysis (450 and 695 nm), both SP and non side population (NSP) cells were collected. SP 
cells showed low staining with Hoe and NSP cells were more brightly stained. A second 
488 nm argon laser (100 mW) was used to excite PI fluorescence for excluding dead cells. 
Results were analyzed using the Summit v3.1 software (Cytomation, Dako, Glostrup, 
Denmark).  
2.2.2 Profiles of isolated subpopulations by Hoe/FACS  
SP cells should be present in the low forward scatter (FSC) and the low side scatter (SSC) 
fractions. There are two scatter plots reflected the distribution of cells, and a very low profile 
of SP (Fig. 1A) cells was shown. According to PI tests, there were about 30.8% dead cells in 
the Hoe stained cells (Fig. 1C). In group A, the percentage of SP was 1.4 ± 0.01% (Fig. 1B). 
When exclusion of the dye was inhibited by Verapamil in group B, the SP cells almost could 
not be discriminated from the MHCC97 cell line (Fig. 1D).  
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2.3 Rho/FACS 
2.3.1 Cells sorting by Rho/FACS  
The cells in group C were stained with Rho (Sigma Chemical Co., St. Louis, MO) at a 
concentration of 0.1 μg/ml (37 °C for 30 min) and washed with PBS/2%FBS twice. The cells 
in group D, which were used to define fluorescence threshold, were co-incubated in the 
presence of Verapamil (50 μM) and Rho for 30 min at 37 °C. All the above cells were 
centrifuged and suspended in PBS/2%FBS containing 10 μg/ml PI to extrude dead cells. 
Flow cytometric analysis of Rho fluorescence at 485 nm was carried out with Aria flow 
cytometer (Becton Dickinson cooperation, Mountain View, CA). Similar to Hoe/FACS, two 
filters were selected to discriminate cell subpopulations. As the Rho dye is activated through 
the FITC filter (Wang et al., 2006), the combination of FITC and PerCP-Cy5.5 filters was 
found optimal. The low Rho fluorescence and Verapamil negative was designated as Rholow 
subpopulation, and the remaining cells were Rhohigh subpopulation.  
2.3.2 Profiles of isolated subpopulations by Rho/FACS 
Rholow cells should be present in the low FSC and the low SSC fractions. There are two 
scatter plots reflected the distribution of cells, and a very low profile of Rholow (Fig. 1E) cells 
was shown. According to PI tests, there were about 30.8% dead cells in the Rho stained cells 
(Fig. 1G), much fewer dead cells than in the Hoe stained cells. In group C, the percentage of 
Rholow in total cells was 2.1 ± 0.02% (Fig. 1F). When the exclusion of Rho dye was inhibited 
by Verapamil, the Rholow cells could not be discriminated from the MHCC97 cell line either 
(Fig. 1H). 
2.4 Cross detection of cell phenotypes 
To further compare the effects of Hoe and Rho on CSCs sorting, the cross detection of SP 
and Rholow cells was done. After the SP cells were isolated, they were immediately 
incubated with 0.1 μg/ml Rho (at 37 °C for 30 min) for Rho fluorescence analyzing. 
Meanwhile, the freshly isolated Rholow cells were also evaluated by Hoe dyeing. The Rholow 
(Fig. 1I) and SP (Fig. 1K) cells contained much fewer cells than the unsorted cells. The SP 
cells in Rholow subpopulation was 52.5 ± 0.29% (Fig. 1J), in contrast, the Rholow cells in SP 
subpopulation was 72.7 ± 0.36% (Fig. 1L). Based on the above results, the ability of Rho 
staining to separate subpopulations from the MHCC97 cell line is similar to Hoe staining. 
2.5 Comparison of the proliferative and self-renewal ability of SP and Rholow cells  
The cells were adjusted to 1×107/ml and seeded in six-well plates (5×105 cells per well). Each 
kind of cells had 7 parallel samples. The culture media was changed every two days. During 
7 days period, in each group, the cells of one parallel sample were trypsinized at 8 o’clock 
each day. Then the cells were counted under an inverted microscope (BX50-32E01, 
Olympus, Tokyo, Japan). As Fig. 2A shows the Rholow cells with stronger ability of self-
renewal and shorter doubling time than the Rhohigh cells (P < 0.05). The Rholow cells doubled 
their number in 16.9 ± 0.24 h; the Rhohigh cells doubled in 25.4 ± 0.28 h. Besides, the Rholow 
cells had a bigger multiplication number than the Rhohigh cells (P < 0.05). The biggest 
multiple of the Rholow cells was 15.2 ± 0.15 and that of the Rhohigh cells was 12.3 ± 0.18. Thus, 
the Rholow (Fig. 2B) and Rhohigh (Fig. 2C) cells had greatly different densities 3 days after 
cultivation. Through statistical assay, the SP cells had little shorter doubling time (16.2 ± 0.23 
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h) and a slightly bigger multiplication number (15.7 ± 0.21) than the Rholow cells (P > 0.05). 
Taken together, the Rholow cells had similar ability to the SP cells for self -renewal. 
 
 
Fig. 1. The profiles of cell subpopulations in the MHCC97 cell line 
(A), when total cells were stained with Hoe (p1), the blue population indicated possible SP 
cells with low fluorescence. (B), parts of them were demonstrated to be true SP cells (p3), 
parts were non SP cells (p4). (C), the viable and dead cells were determined by PI. (D), the 
profile of SP population (p3) decreased in the presence of Verapamil. (E), the distribution of 
total cells stained with Rho. (F), the Rholow cells were shown as a low Rho fluorescence (p2) 
and the Rhohigh cells were with high fluorescence (p3). (G), the most cells were viable. (H), 
when the cells were treated with Verapamil, the fluorescence of the Rholow cells was shifted 
to a higher level (p3). The distributions of (I) the Rholow cells stained with Hoe (p1) and (K) 
the SP cells stained with Rho (p1). (J), the percentage of the SP cells in Rholow (p2). (L), the 
percentage of Rholow cells in SP (Q3). 
We also designed soft agar clone formation test to compare the self-renewal capacity of cells 
from each subpopulation. The 2×DMEM (containing 200 ml/L FCS) were mixed with equal 
volume agarose (12 mg/ml) (Sigma Chemical Co., St. Louis, MO) as the bottom-layer agar. 
The cells from SP, NSP, Rholow and Rhohigh were diluted to 1×104 cells/ml and put on the 
bottom-layer agars, respectively. Immediately, the cells were covered with the top-layer 
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agars, which consisted of agarose (7 mg/ml) and equal volume 2×DMEM. Culture for 14 
days, the number of cell clones was counted. After culture for 14 days, most of the SP and 
Rholow cells had formed cell clones. The rate of clone formation in the SP cells was 73.5 ± 
0.12%, and that in the Rholow cells (Fig. 2D) was 70 ± 0.11%. In contrast with the SP and 
Rholow cells, the NSP and Rhohigh cells had much lower clone formation rates (P < 0.01). Such 
as the clone formation rate in the NSP cells was 25.2 ± 0.06%, and that in the Rhohigh cells 
(Fig. 2E) was 30.4 ± 0.07%. 
 
 
 
Fig. 2. The proliferative abilities of different typed cells 
(A), cell growth curve. (B) the Rholow and SP cells from the MHCC97 cell line had a stronger 
capacity to proliferate than (C) the Rhohigh and NSP cells, respectively. The cell clones 
formed by (D) the Rholow cells was much bigger than that by (E) the Rhohigh cells. 
Magnification: panels B-D, ×100. 
2.6 Cell marker expression 
2.6.1 Immunocytochemical assay 
One early hepatic marker was selected to evaluate the maturity of the cells from different 
subpopulations. First-anti AFP mAb (Zhong-Shan Co., Beijing, China) (1μl) was diluted 
with PBS (99 μl) to a working density. The cells from different subpopulations (1×104/ml) 
were incubated with mAb, coloured by DAB (Zhong-Shan Co., Beijing, China), and stained 
by hematoxylin. In negative control groups, the PBS was adopted instead of first antibody. 
These cells were periodically viewed under an inverted microscope. When the appearance 
of Buffy colour particles showed in the cytoplasm, the result was identified positive. The 
positive cells were counted and their percentage was calculated. The percent of AFP positive 
cells<10% was defined as negative (-), 10–25% as positive (+), 25–50% as moderate positive 
(++), >50% as strong positive (+++). We collected and incorporated the same 
immunocytochemical results. The detailed data have been enumerated in Table 1. The 
Rholow (Fig. 3A) and SP cells (Fig. 3C) expressed higher AFP than the Rhohigh (Fig. 3B) and 
NSP (Fig. 3D) cells, respectively (P < 0.01). Besides, the SP cells had similar expression level 
of AFP to the Rholow cells (P > 0.05) (Fig. 3I). These results demonstrated the cells were 
immature and from hepatic carcinoma. 
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cell 
subpopulation 
sample number AFP- AFP+ AFP++ AFP+++ 
Rholow a 35 1±0.14 6±0.28 20±0.86 8±0.28 
Rhohigh 35 10±0.43 16±0.56 6 ±0.28 3±0.14 
SP b 35 1±0.14 4±0.14 21±0.86 9±0.43 
NSP 35 12±0.43 15±0.56 5±0.14 3±0.14 
Table 1. The expression of AFP in cell subpopulation 
All AFP immnocytochemical data were viewed by three different researchers and expressed 
as mean±SD. a Rholow VS Rhohigh , N=35, P<0.05; b SP VS Rholow, N=35, P>0.05. 
2.6.2 Immuno-flow cytometric analysis 
One CSCs marker was applied to identify the characters of CSCs in each subpopulation. The 
freshly isolated Rholow, SP, NSP and Rhohigh cells were prepared as single-cell suspensions at 
a density of 1×106 cells/ml, incubated with 0.075 ml CD133 mAb (Zhong-Shan Co., Beijing, 
China) for 30 min at 4 °C, washed in PBS twice, and fixed in 0.1% formaldehyde for flow 
cytometric analysis. Irrelevant isotype matched mAb was used as negative controls. Dead 
cells were excluded by PI gating. The percentage of CD133 positive cells in Rholow (Fig. 3E) 
was 51.84 ± 0.33%, in Rhohigh (Fig. 3F) was 13.36 ± 0.11%, in SP (Fig. 3G) was 53.24 ±0.42%, 
and in NSP (Fig. 3H) was 12.70 ± 0.10%. The CD133 expressed significantly different among 
these subpopulations (P < 0.01) (Fig. 3J). 
AFP expressed in (A) the Rholow cells was strongly higher than that in (B) the Rhohigh cells; 
AFP expressed higher in (C) the SP cells than in (D) the NSP cells. For figures (E)-(H), the 
black histogram was the isotype control, and the red histogram was the trial. A fluorescent 
value was set as the regional marker (brunneus bar), which must be just bigger than the 
fluorescent values of cells in control group. Then the fluorescent value was remembered and 
used as the regional marker (brunneus bar) in trial group. The positive region was where the 
fluorescent values were bigger than the set fluorescent value in trial group. The percentages 
of the CD133 positive cells in (E) Rholow and (G) SP were also higher than those in (F) Rhohigh 
and (H) NSP, respectively. The detailed expressions of (I) AFP and (J) CD133 are reflected 
by column charts. Magnification: panels A-D, ×400. 
2.7 Tumor formation in nude mice 
The gold standard for measuring tumor initiating potential is to assess the capacity of cells 
to form tumors when injected into immune-deficient mice. Using this model, we tended to 
check the differentiating ability of the cells from each subpopulation. Thirty-two male 
BALB/C nude mice (Fourth Military Medical University, Xi’an, China) were maintained 
under standard conditions according to the College’s guidelines. The freshly isolated SP, 
NSP, Rholow and Rhohigh cells (1×106) were injected into the right back of mice, respectively. 
When the xenograft tumors grew to proper size, the mice were sacrificed and the tumor 
tissues were collected, fixed in 4% formaldehyde, and embedded in paraffin for H&E 
staining to assess tumors histology. To avoid subjective bias, each chip was marked with     
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Fig. 3. The expressions of CSCs markers 
one number within 1–1 to 1–7 (SP), 2–1 to 2–7 (NSP), 3–1 to 3–7 (Rholow) and 4–1 to 4–7 
(Rhohigh), and viewed by three different pathologists. Based on the tumor size, no 
macroscopic tumor was defined as negative (-), the diameter of tumor <0.2 cm as positive 
(+), 0.2–0.5 cm as moderate positive (++), >0.5 cm as strong positive (+++).Since the mice 
were injected with cells from different subpopulations, they were checked each day. The 
xenograft tumors grew to proper size 5 weeks later, within the mice which were injected 
with SP or Rholow cells, however, we couldn’t find obvious tumor in some mice injected with 
NSP or Rhohigh cells. We counted the number of tumors in each mouse, measured the size of 
each tumor and summarized those data in Table 2. The tumor formation rate in mice with 
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SP cells injected was 78.0 ± 1.21%, and that with Rholow cells injected was 66.0 ± 1.03%. In 
addition, the rate in mice with Rhohigh cells injected was <15.0%. This indicates that the 
Rholow cells had stronger ability to form tumors in vivo than the Rhohigh cells (P < 0.01); 
however, the Rholow cells (Fig. 4A) had slightly lower ability to form tumors than the SP 
cells (P > 0.05) (Fig. 4B). Part of each tumor was made into chips and stained by H&E (Fig. 
4C–F) to assess tumor pathology. According to three different pathologists’ judgements, the 
tumors were all hepatic tumor genesis, which could help us discriminate the neoplasms 
from other kinds of tumors. After the cells from some tumors were isolated and cultured, 
we used flow cytometry to analyze the phenotype of those cells. Through our analysis, the 
tumors generated by the injected cells, were mainly from the SP or Rholow cells. 
 
cell 
subpopulation 
sample number tumor- tumor+ tumor++ tumor+++ 
Rholow a 28 1±0.11 12±0.51 11±0.28 4±0.14 
Rhohigh 28 17±0.36 7±0.21 4±0.15 0±0.00 
SP b 28 1±0.11 10±0.23 8±0.24 9±0.21 
NSP 28 19±0.36 6±0.20 3 ±0.12 0±0.11 
 
Table 2. The tumor formation rate of cell subpopulation in nude mice 
All the mice were checked carefully and wholly for tumors, and the diameter of each tumor 
was measured. a Rholow VS Rhohigh, N=28, P<0.01; b SP VS Rholow, N=28, P<0.05. 
 
 
 
 
Fig. 4. Tumor formation capacity of each typed cells 
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Both (A) the Rholow and (B) SP cells formed different sized tumors. H & E dyeing revealed 
the tumors formed by (C) the Rholow, (D) Rhohigh, (E) SP and (F) NSP cells were all hepatic 
carcinoma genesis. Magnification: C-F,×100. 
2.3 Comparison of two methods 
The cells that exclude Hoe dye are SP cells. Because the SP cells express high levels of stem 
cell markers and low levels of differentiating markers (Haraguchi et al., 2006), the SP 
subpopulation is widely used to enrich stem cells. Early in 1993, with a sequential Hoe/Rho 
sorting system, the subfractions of cells that stained most weakly with both dyes were 
demonstrated to be long-term repopulating primitive hematopoietic cells (Wolf et al., 1993). 
Again in 2004, Bertoncello and Williams found that the supravital dyes Rho and Hoe have 
proven to be remarkably powerful probes for the characterization, resolution, isolation and 
purification of primitive hematopoietic stem cells (PHSCs) (Bertoncello & Williams, 2004). 
However, since the cytotoxicity of Hoe is confirmed in recent years (after 2004) (Adamski et 
al., 2007), the combination of the two dyes is rare.  
There are two major limitations in the SP research. First one is the toxicity of Hoe (Kondo et 
al., 2004). It is demonstrated that Hoe interferes with C2C12 cell fusion as long as the dye is 
present in the nucleus (Adamski et al., 2007), more and more researchers have found that 
Hoe staining can affect on cell differentiation. For each cell line, the Hoe concentration 
should be optimised to minimize cytotoxicity. Second one is the requirement of an UV laser 
to excite the Hoe dye. The flow cytometer equipped with UV sources is expensive to own 
and operate and is not readily available to many laboratories or institutions. To solve this 
problem, some researchers (Cabana et al., 2006) tried to design a minimum UV excitation 
implement for measuring Hoe. At present, the related endeavor is still undergoing. 
However, the major toxic drawback of Hoe remains unsolved. Thus, it may be better to find 
a replacement of Hoe in isolating stem-like cells. Like Hoe, Rho is actively pumped out of 
the cells by ABC transporters. Some researches have also shown that no toxicity on cells is 
found by Rho, even at large dose (1–10 mM) (Ribou et al., 2003). In our study, we tested the 
cytotoxic effects of the two dyes and found Hoe was much more harmful to cells than Rho. 
That is to say, the Rho dye avoided one main disadvantage of the Hoe dye for CSCs 
isolation. Besides, to perform Rho/FACS, it only needs a common flow cytometer, in which 
the fluorescence is activated by argon-ion or helium–cadmiumlaser. The common flow 
cytometer is a lower cost (both in terms of purchase and maintenance) than cytometers 
offering UV excitation. Our FACS results indicate the percentage of SP was slightly lower 
than that of Rholow in the MHCC97 cell line. It does not mean that Rho can accumulate more 
CSCs than Hoe. The reason may be that the purity of CSCs in Rholow is lower. Based on the 
cross detections of SP and Rholow cells, the percentage of CSCs in total cells may be 1% 
(72.7% Rholow cells in 1.4% SP subpopulation; 52.5% SP cells in 2.1% Rholow subpopulation). 
In other words, the combination of Rho/FACS and Hoe/FACS may enrich much purer 
CSCs, which is consistent with others. 
Based on the analysis of several CSCs characteristics, we found the Rholow cells had similar 
characters as the SP cells, such as high proliferative ability and high expression of CD133. 
The use of CD133 has proven to be very successful in the identification of CSCs in both 
human brain and colon carcinomas (O’Brien et al et al., 2007). Interestingly, about 5 days in 
culture, Rhohigh and NSP subpopulations reached a plateau in the growth curve. The reasons 
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maybe parts of the cells in NSP or Rhohigh became older and older and finally died. 
Meanwhile, a few of stem cells gave birth to new cells. The number of dead cells was similar 
to that of the new-born cells. However, the cells from SP and Rholow were mostly stem cells, 
which were long lived and could continually differentiate into different typed cells. These 
cells would continue proliferating for a long time. In addition, we found that the Rholow and 
SP cells had similar tumor formation rates and the H&E staining confirmed the tissues 
hepatic genesis. In one word, the Rholow and SP cells shared similar characters both in vivo 
an in vitro. That is to say, although Rho/FACS is not as effective as Hoe/FACS to isolate 
stem cells, given its low cytotoxicity and low cost, it may replace Hoe/FACS in isolating 
some typed CSCs. 
 
2.4 Limitations 
Although many findings support the isolation of SP cells via Hoe and Rho staining as an 
identification method for CSCs, some controversial results were obtained regarding the 
expressions of specific stem cell/CSC markers on SP cells. Burkert et al found that SP cells 
of several gastrointestinal cancer cell lines showed no increased expressions of stem cell 
markers like CD133, CD44, Musashi-1, Oct-4 and CD117 compared to non-SP cells. Both 
fractions were similarly clonogenic in vitro, tumorigenic in vivo, and displayed similar 
differentiation potential in vitro and in vivo (Burkert et al., 2008). Due to these 
controversial findings, dyes efflux and isolation of SP cells can not be applied to identify 
and isolate CSCs, at least for some tumor entities. Various cell types needs different 
optimized protocols, such as single cell suspension levels, optimal dye concentration, 
concentration of Verapamil, the density of cells in culture and so on. Optimized and 
standardized protocols for each cell type as well as stringent cell culture and isolation 
settings are required to eliminate the risk of analyzing different SP cells. These standards 
will help to abolish skepticism and uncertainty about the general validity of the technique 
and potential of SP cells. 
 
3. Conclusion 
Based on the results, we get these conclusions: firstly, to isolate CSCs from the MHCC97 cell 
line, the effectiveness of Rho/FACS in enriching CSCs is similar to that of Hoe/FACS. 
Secondly, the Rholow cells had similar characters as the SP cells; lastly, the Rho/FACS is less 
toxic and expensive than the Hoe/FACS. To conclude, when the Hoe/FACS is too toxic or 
expensive to do biological researches of some typed stem cells, the Rho/FACS is still 
another elective method. To conclude, in circumstances where suspected cancer stem-like 
cells may be susceptible to Hoe toxicity and/or where the cost of UV-FACS is prohibitive, 
the application of Rho/FACS is a credible method of isolation. 
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